Abstract:The computer-aided drug design field is constituted by a wide range of different approaches that can be roughly classified as either ligand- or receptor-based techniques. In order to design and develop new active ligands, ligand-based approaches use the information derived from the properties of ligands with known activity against the target of interest, whereas the receptor-based techniques use the information obtained from the knowledge of the three-dimensional structure of the target and from the analysis of ligand–receptor interactions. With regards to the receptor-based techniques, one of the key steps of almost all approaches is represented by the estimation of the binding strength between the ligand and the receptor. Indeed, a proper evaluation of this interaction can be profitably used to design new ligands characterized by a tighter binding with the target of interest. Unfortunately, the main limitation of docking calculation resides in the estimation of the ligand–receptor interaction, which is usually evaluated through simple scoring functions. In particular, the scoring functions are used for both qualitative and quantitative studies: they are used for ranking different binding poses of the same ligand, thus providing its most reliable binding orientation, and they can also be used for comparing from an energetical point of view the interaction of different ligands with the same receptor, thus ranking the ligands according to the relative binding affinities. Although the available scoring functions are able to suggest the most reliable binding orientation for a ligand, their ability to predict ligand-receptor binding affinity and correctly rank different ligands on this basis is often not satisfactory enough. Among the different approaches that can be applied to evaluate the ligand–receptor interaction, the accurate measurement of binding free energy plays a very important role and, in this field, the most rigorous theoretical method is represented by free-energy perturbation (FEP), which estimates the difference in free energy between two states by slowly changing one state to another through a number of nonphysical intermediate states, performing extended sampling at each intermediate state [<a href="#">1</a>]. Unfortunately, this method is extremely time consuming and therefore more approximate methods have been developed. In this context, the molecular mechanics Poisson–Boltzmann surface area (MM/PBSA) and molecular mechanics generalized Born surface area (MM/GBSA) developed by Kollman et al. [<a href="#">2</a>,<a href="#">3</a>] are among the most commonly used methods.

The Development of a Weighted Index to Optimise Compound Libraries for High Throughput Screening

Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening

Alternative weighting schemes for fine-tuned extended similarity index calculations

Adaptive designs for identifying optimal biological dose for molecularly targeted agents.

Reaction-Based Enumeration, Active Learning, and Free Energy Calculations To Rapidly Explore Synthetically Tractable Chemical Space and Optimize Potency of Cyclin-Dependent Kinase 2 Inhibitors

Quantitative Hydrogen-Deuterium Exchange Mass Spectrometry for Simultaneous Structural Characterization and Affinity Indexing of Single Target Drug Candidate Libraries

Using macromolecular electron densities to improve the enrichment of active compounds in virtual screening

A high quality, industrial data set for binding affinity prediction: performance comparison in different early drug discovery scenarios

Metabolite Measurement in Index Substrate Drug Interaction Studies: A Review of the Literature and Recent New Drug Application Reviews

Compound Libraries: Recent Advances and Their Applications in Drug Discovery.

Machine Learning Assisted Hit Prioritization for High Throughput Screening in Drug Discovery

High-throughput mechanistic screening of non-equilibrium inhibitors by a fully automated data analysis pipeline in early drug-discovery

Data Valuation: A novel approach for analyzing high throughput screen data using machine learning

Machine Learning-Driven Data Valuation for Optimizing High-Throughput Screening Pipelines

Enhanced Sampling of Chemical Space for High Throughput Screening Applications using Machine Learning

True Accuracy of Fast Scoring Functions to Predict High-Throughput Screening Data from Docking Poses: The Simpler the Better

Enrichment of chemical libraries docked to protein conformational ensembles and application to aldehyde dehydrogenase 2

Efficient Exploration of Chemical Space with Docking and Deep Learning

What is the current value of MM/PBSA and MM/GBSA methods in drug discovery?

Pareto Optimization to Accelerate Multi-Objective Virtual Screening